Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 81376

HLA Class II typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each.

Use the fewest codes necessary to describe the testing performed. Do not report preparatory work prior to cell lysis (e.g., microdissection) with this code; these are billed separately.

Modifier 26 can be appended if only the professional component (interpretation and report) is performed by the physician.

Medical necessity for HLA typing is determined by the clinical context. It must be justified by the patient's condition, such as a need for a transplant or evaluation for a specific HLA-associated disease.

The lab analyst performs all technical aspects of the test.Physician interpretation and report can be separately billed using modifier 26 with G0452.

IMPORTANT:When low resolution typing is performed for HLA-DRB1/3/4/5 and -DQB1, use 81375. When HLA typing includes determining the presence or absence of DRB3/4/5 genes, that service is included and not reported separately. When low or intermediate resolution typing of any or all DRB3/4/5 genes is performed, it's treated as one locus. If the test involves all Class II loci (HLA-DRB1/3/4/5 and -DQB1), use 81375 instead of three units of 81376.

In simple words: This test examines specific genes called HLA genes that help your body's immune system recognize its own cells. It's often used before transplants to see how well a donor and recipient match, or to check for genes linked to certain diseases.The test focuses on a small part of these genes, giving a general idea of their makeup rather than a very detailed picture.

This code represents the laboratory testing for Human Leukocyte Antigen (HLA) Class II typing at low or intermediate resolution for a single locus using molecular techniques.The procedure includes all analytical steps involved in the test, starting from nucleic acid extraction (e.g., cell lysis, digestion) to identification of the target HLA gene sequences (e.g., amplification, hybridization with nucleic acid probes, or direct sequencing-based typing). The resolution of typing identifies alleles without high specificity, such as to the two-digit HLA name, or using broader classifications like a string of alleles or a National Bone Marrow Donor Program code. Examples of Class II loci include HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1. While not restricted to specific conditions, this test is often used for assessing donor/recipient compatibility in solid organ or hematopoietic stem cell transplants, or for identifying HLA Class II alleles associated with particular disease states.

Example 1: A patient awaiting a kidney transplant needs HLA typing to assess compatibility with potential donors., A patient with a suspected autoimmune disease undergoes HLA typing to check for the presence of specific alleles associated with the condition., A patient requires a bone marrow transplant, necessitating HLA typing for donor matching.

Documentation should include the reason for testing (e.g., transplant, disease diagnosis), the specific locus tested, and the resolution of typing performed (low or intermediate). The report should clearly identify the alleles present.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.